Credit Suisse’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6	Closed	–	–	4206
2022 Q2	$0	Buy	+6	New	–	﹤0.01%	4205
2021 Q4	–	Sell	-6,950	Closed	-$216K	–	3702
2021 Q3	$216K	Buy	+6,950	New	+$216K	﹤0.01%	3361